2023
DOI: 10.1016/j.bjorl.2023.01.007
|View full text |Cite
|
Sign up to set email alerts
|

The development of nasal polyps involves early middle meatus mucous remodeling via TGF-β1 mediated PAI-1 reduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…The TGFβ1 signaling pathway has been involved in fibrous remodeling phenomena in several type 2 inflammatory diseases, including bronchial asthma [97,98], atopic dermatitis [99], allergic rhinitis [100], nasal polyposis [101], and idiopathic eosinophilic pneumonia [102], all of them sharing common pathophysiological mechanisms with EoE. The inflammatory and fibrotic phenomena described in these organs are similar to those observed in EoE, and despite the differences in intimate molecular mechanisms, it was assumed that the patterns that occur in asthma [50] could be largely extrapolated to EoE [103].…”
Section: Contribution Of Tgf-β1 To Fibrosis In Eoe: Distinct Methods ...mentioning
confidence: 99%
“…The TGFβ1 signaling pathway has been involved in fibrous remodeling phenomena in several type 2 inflammatory diseases, including bronchial asthma [97,98], atopic dermatitis [99], allergic rhinitis [100], nasal polyposis [101], and idiopathic eosinophilic pneumonia [102], all of them sharing common pathophysiological mechanisms with EoE. The inflammatory and fibrotic phenomena described in these organs are similar to those observed in EoE, and despite the differences in intimate molecular mechanisms, it was assumed that the patterns that occur in asthma [50] could be largely extrapolated to EoE [103].…”
Section: Contribution Of Tgf-β1 To Fibrosis In Eoe: Distinct Methods ...mentioning
confidence: 99%
“…TGF-β regulates thrombosis by acting as an inducer of plasminogen activator inhibitor 1 (PAI-1) [ 99 ]. At both the transcriptional and protein levels, TGF-β1, PAI-1, and tissue-type plasminogen activators are found to be decreased in both early-stage and mature nasal polyps compared to healthy sinonasal epithelium [ 100 ]. In nasal mucosa-derived fibroblasts of patients with CRSsNP, thromboxane A2 plays a key role in controlling the expression of chemokines CXCL1 and CXCL8, which are found at high levels in the nasal mucosa of patients with CRSsNP.…”
Section: Epithelial Cell–ecm Crosstalkmentioning
confidence: 99%